In the US, Sorafenib (sorafenib systemic) is a member of the following drug classes: multikinase inhibitors, VEGF/VEGFR inhibitors and is used to treat Hepatic Tumor, Hepatocellular Carcinoma, Renal Cell Carcinoma and Thyroid Cancer.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Tyrosine kinase inhibitor
- Sorafenibum (Latin)
- Sorafenib (German)
- Sorafénib (French)
- Sorafenib (Spanish)
- Sorafenib (OS: USAN, BAN)
- BAY 43-9006 (IS: Onyx, Bayer)
- Sorafenib Tosilate (OS: BANM, JAN)
- Sorafenib Tosylate (OS: USAN)
- Sorafenib tosylat (IS)
Bayer, Bosnia & Herzegowina; Bayer, China; Bayer, Egypt; Bayer, Hong Kong; Bayer, Lebanon; Bayer, Turkey; Bayer HealthCare, Singapore; Bayer Schering, Taiwan; Bayer Thai Co Ltd, Thailand; Bayer, Belgium; Bayer, Canada; Bayer, Chile; Bayer, Colombia; Bayer, Denmark; Bayer, Ecuador; Bayer, Spain; Bayer, United Kingdom; Bayer, Greece; Bayer, Croatia (Hrvatska); Bayer, Hungary; Bayer, Ireland; Bayer, Italy; Bayer, Latvia; Bayer, Netherlands; Bayer, New Zealand; Bayer, Oman; Bayer, Philippines; Bayer, Poland; Bayer, Portugal; Bayer, Romania; Bayer, Sweden; Bayer, Slovakia; Bayer Health Care, Malaysia; Bayer HealthCare, Finland; Bayer HealthCare, Russian Federation; Bayer HealthCare, United States; Bayer Pharma, Austria; Bayer Pharma AG, Norway; Bayer Santé, France; Bayer Schering, Australia; Bayer Schering, Czech Republic; Bayer Schering, Lithuania; Bayer Schering, Serbia; Bayer Schering, South Africa; Bayer Vital, Germany; Bayer Yakuhin, Japan; Bayer-Schering, Iceland; Emra-Med Arzneimittel, Austria; Eurim-Pharm, Austria; Haemato Pharm, Austria; Orifarm, Norway
|BAN||British Approved Name|
|BANM||British Approved Name (Modified)|
|IUPAC||International Union of Pure and Applied Chemistry|
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.